Mining of databases comprising of genome and proteome changes in GBM patients led to discovery of a subset of GBM associated with NHE9 overexpression.4 Notably, tumours in this subset are non‐responsive to radiation and chemotherapy. Here, SLC9A9 is linked to neoplasm.